Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
08/22/2001 | EP1124965A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
08/22/2001 | EP1124964A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
08/22/2001 | EP1124962A1 Maize kin17 orthologues and uses thereof |
08/22/2001 | EP1124961A2 Thrombopoietic compounds |
08/22/2001 | EP1124959A1 Cell surface molecule-induced macrophage activation |
08/22/2001 | EP1124958A2 Corticosteroid synthesis-associated genes |
08/22/2001 | EP1124957A1 Pholasin |
08/22/2001 | EP1124955A1 CDNA SEQUENCE AND GENOMIC ORGANIZATION FOR A 59.4 KDA NEURONAL-SPECIFIC 7 TRANSMEMBRANE PROTEIN (pNEU60) |
08/22/2001 | EP1124951A2 Human sorting nexins |
08/22/2001 | EP1124947A2 Construction of production strains for producing substituted phenols by specifically inactivating genes of the eugenol and ferulic acid catabolism |
08/22/2001 | EP1124946A1 Glycosylated proteins having reduced allergenicity |
08/22/2001 | EP1124944A2 Mutant luciferase having increased thermostability |
08/22/2001 | EP1124943A1 Nucleic acids encoding taxus geranylgeranyl diphosphate synthase, and methods of use |
08/22/2001 | EP1124855A2 Compositions and methods for treating polycystic kidney disease |
08/22/2001 | EP1124852A1 Lysine-rich statherin protein |
08/22/2001 | EP1124850A1 12 human secreted proteins |
08/22/2001 | EP1124849A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
08/22/2001 | EP1124848A2 Transmembrane 4 proteins |
08/22/2001 | EP1124846A2 Nucleotide and protein sequences of nogo genes and methods based thereon |
08/22/2001 | EP1124844A1 G protein-coupled receptor resembling the thrombin receptor |
08/22/2001 | EP1124843A1 Low allergenic protein variants |
08/22/2001 | EP1124840A1 Ovary-specific genes and proteins |
08/22/2001 | EP1124592A2 Textured and porous silicone rubber |
08/22/2001 | EP1124590A1 Enzyme-mediated modification of fibrin for tissue engineering |
08/22/2001 | EP1124583A1 Adeno-associated vectors for expression of factor viii by target cells |
08/22/2001 | EP1124577A1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS |
08/22/2001 | EP1124576A2 Method for preparing solid phase conjugate vaccines |
08/22/2001 | EP1124572A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
08/22/2001 | EP1124570A2 Novel neuropilin/growth factor binding and uses thereof |
08/22/2001 | EP1124417A2 Compositions comprising plant cell growth regulating compounds and methods of use thereof |
08/22/2001 | EP1124411A1 New plants formed by microparticle bombardment with uncharacterised dna |
08/22/2001 | EP0991402A4 Poly(vinyl alcohol) cryogel |
08/22/2001 | EP0904354A4 NOVEL PLANT STEROID 5alpha REDUCTASE, DET2 |
08/22/2001 | EP0725794B1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives |
08/22/2001 | EP0673255B1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
08/22/2001 | CN1309714A Methods and means to modulate programmed cell death in eukaryotic cells |
08/22/2001 | CN1309710A Genomic sequences upstream of coding region of IFN-alpha 2 gene for protein production and delivery |
08/22/2001 | CN1309709A Factors affecting tumor necrosis factor receptor releasing enzyme activity |
08/22/2001 | CN1309708A Postweaning multisystemic wasting syndrome virus from pigs |
08/22/2001 | CN1309707A BASB029 polynucleotide(s) and polypeptides from i(neisseria meningitidis) |
08/22/2001 | CN1309706A Compound from moraxella catarrhalis |
08/22/2001 | CN1309699A Phytase variants |
08/22/2001 | CN1309698A Media for culturing animal cells and process for producing protein by using same |
08/22/2001 | CN1309665A Antibodies capable of detecting beer spoilage lactic acid bacteria and detecting method using same, and reagent kit with same |
08/22/2001 | CN1309664A Anti hepatitis C virus antibody and uses thereof |
08/22/2001 | CN1309663A Anti-angiogenic proteins and methods of use thereof |
08/22/2001 | CN1309569A Composition comprising tumor cells and extracts and method for using thereof |
08/22/2001 | CN1309184A Operation of enzymatic vitality of protoporphyrin primary oxidase in eukaryote |
08/22/2001 | CN1309180A Multi-mesoblast pedigree differential potency for stromal cell from fatty tissue, and its use |
08/22/2001 | CN1309179A In-vitro cell culture model of chicken coccidian and its application |
08/22/2001 | CN1308854A Method of storing plant culture tissue in liquid |
08/21/2001 | US6277979 KIAA0551 polynucleotides and polypeptides use |
08/21/2001 | US6277978 KVLQT1—a long QT syndrome gene |
08/21/2001 | US6277977 cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor |
08/21/2001 | US6277975 Fusions of P-selectin ligand protein and polynucleotides encoding same |
08/21/2001 | US6277972 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
08/21/2001 | US6277971 Dna which codes for nap protein of defined amino acid sequence; diagnosis and treatment of acquired immune deficiency syndrome (aids) |
08/21/2001 | US6277970 PRP-like gene |
08/21/2001 | US6277965 Amino acid sequence of cysteinyl trna (transfer ribonucleic acid) synthetase from chlamydia; bactericides; bacteriostats; enzyme inhibitors; drug screening; diagnosis; vaccines |
08/21/2001 | US6277964 Anti-PAH monoclonal antibodies and cell lines producing the same |
08/21/2001 | US6277962 Receptor on the surface of activated t-cells: act-4 |
08/21/2001 | US6277960 Amino acid sequence of g protein coupled receptor; treatment of eating disorders, asthma, parkinson's disease, cardiovascular and nervous system disorders, huntington's disease, tourett's syndrome, and others; diagnosis |
08/21/2001 | US6277959 Isolated mammalian membrane protein genes; related reagents |
08/21/2001 | US6277956 Isolated peptide of defined amino acid sequence which binds to a hla-a2 (human leukocyte antigen-a2) and provokes proliferation of cytolytic t cells; immunology; oncology; vaccines |
08/21/2001 | US6277863 Anticoagulant with reduced side effects |
08/21/2001 | US6277823 Isolated from xenorhabdus nematophilus, xenorhabdus poinarii, and photorhabdus luminescens to control insect pests or in transgenic plants to confer insect resistance |
08/21/2001 | US6277822 Family of peptides known as xenoxins |
08/21/2001 | US6277820 Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells |
08/21/2001 | US6277635 Use of interleukin-10 to produce a population of suppressor cells |
08/21/2001 | US6277634 Hybridized with target rna to be cleaved; medical diagnosis or gene therapy, drugs |
08/21/2001 | US6277633 Lentivirus-based gene transfer vectors |
08/21/2001 | US6277621 Artificial chromosome constructs containing foreign nucleic acid sequences |
08/21/2001 | US6277620 Polypeptide for the prevention of bacterial infection; bactericides; for vaccine development |
08/21/2001 | US6277600 Trimeric chimera protein and collagen matrix containing chimera protein |
08/21/2001 | US6277599 Monoclonal antiboby for the preferential killing of tumors; for diagnosis of cancer; for the treatment of cancer |
08/21/2001 | US6277598 Nucleotide sequences associated with the activation of immunocompetent cells; for the reduction of side effects associated with cancer treatment; for amplifying cytotoxicity of killing cells; for the treatment viral diseases |
08/21/2001 | US6277594 Neurogenesis inducing gene |
08/21/2001 | US6277593 Generating preferential polypeptide; culture transformed cells, express preferential polypeptide, recover preferential polypeptide |
08/21/2001 | US6277590 Genetically engineered aggregates for generating preferential heterologous proteins |
08/21/2001 | US6277585 Vertebrate unc-5 proteins which function as receptor proteins for netrins, a family of cell guidance proteins; use in diagnosis, therapy and in the biopharmaceutical industry |
08/21/2001 | US6277575 Process aimed at evidencing the state of a malignant cell |
08/21/2001 | US6277574 Genes associated with diseases of the kidney |
08/21/2001 | US6277564 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
08/21/2001 | US6277561 Isolation and characterization of retrovirus from the hiv group via hybridization of oligonucleotide to nucleic acid indicating the presence of immunodeficiency virus (mvp-5180/91) |
08/21/2001 | US6277419 Contains such very strong sweet substances such as stevioside and rebaudioside. |
08/21/2001 | US6277373 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase |
08/21/2001 | US6277372 Porcine ventral mesencephalic cells obtained from an embryonic pig of between ages 24 and 30 of gestation from embryonic connective tissue; |
08/21/2001 | US6277369 The selected cells can thereafter be used as vehicles for transferring genes encoding a therapeutic protein to a mammal, including humans. |
08/16/2001 | WO2001059458A1 Specific monoclonal antibody against terbinafine |
08/16/2001 | WO2001059450A2 Cells expressing zinc finger protein for drug discovery |
08/16/2001 | WO2001059152A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
08/16/2001 | WO2001059140A1 Transgenic cells expressing glucosyltransferase nucleic acids |
08/16/2001 | WO2001059138A2 Plant internal ribosome entry segment |
08/16/2001 | WO2001059133A1 Larynx carcinoma-associated protein larcap-1 |
08/16/2001 | WO2001059130A2 Proteins producing an altered immunogenic response and methods of making and using the same |
08/16/2001 | WO2001059129A2 Mammalian secreted group iii phospholipase a2 |
08/16/2001 | WO2001059127A2 Drug metabolizing enzymes |
08/16/2001 | WO2001059126A2 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
08/16/2001 | WO2001059120A2 Il-17 like molecules and uses thereof |
08/16/2001 | WO2001059115A2 83p5g4: a tissue specific protein highly expressed in prostate cancer |